Essen, Germany – Preliminary figures from Evonik show the firm made earnings before interest, tax, depreciation and amortisation of EUR 742m in the first half of the year.
This contrasts with EUR 640m, which the speciality chemicals company made in the first half of 2017. When confirmed in the full half year numbers, due on 2 August, this will represent a 6.2% increase year on year.
Higher sales drove EBITDA growth, Evonik said.
Sales were EUR 3.9bn in the first half of 2018, compared with EUR 3.6bn in the first half of 2017. This represents growth of 8.3% year on year.'
Evonik said that 'the significant increase in earnings resulted from the excellent operating performance in all three chemical segments… robust demand and visible success in reducing costs in administration and sales'.
